You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
昊海生物科技(06826.HK)擬597.4萬英鎊購買CONTAMAC HOLDINGS 9%股權
格隆匯 05-21 18:45

格隆匯5月21日丨昊海生物科技(06826.HK)發佈公吿,於2021年5月21日,Haohai Healthcare Holdings(公司間接全資子公司)與賣方訂立購股協議,據此賣方同意出售及Haohai Healthcare Holdings同意購買目標公司CONTAMAC HOLDINGS LIMITED的9%權益,對價為597.4萬英鎊。

目標公司為一家於英國註冊成立的有限公司,主要從事製造隱形眼鏡及人工晶狀體材料,包括矽膠水凝膠材料、透氣材料、親水透鏡材料以及疏水和親水的眼內透鏡材料。於交易完成後,Haohai Healthcare Holdings將成為目標公司79%權益的持有人。

公司表示,目標公司股東此前已於2017年的先前收購中協定若干認沽期權權利及認購期權權利,其中於賣方的鎖定期屆滿後,賣方具有將待售股份出售予買方的認沽期權權利,而買方則具有自賣方購買待售股份的認購期權權利。考慮到賣方的年事已高及目標公司對集團的重要性,賣方及買方均已同意通過簽訂購股協議行使其權利。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account